Emergent Biosolutions
NYSE: EBSGaithersburg, US · Delaware corporation · 2 known investors
Founders & leadership
GJ
George J. JoulwanDirector
RG
Robert G KramerExecutive Officer
RB
Ronald B RichardDirector
KS
Katherine StreiExecutive Officer
FE
Fuad El-HibriDirector, Executive Officer
AR
Adam R HaveyExecutive Officer
SB
Sue BaileyDirector
DJ
Daniel J Abdun-NabiExecutive Officer, Director
LW
Louis W SullivanDirector
ZH
Zsolt HarsanyiDirector
KC
Kathryn C ZoonDirector
JM
Jerome M HauerDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$47.9MraisedOct 2018 · 8 investors · BiotechnologyRule 506(b)
▶$47.9MraisedOct 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George J. JoulwanDirector
- Robert G KramerExecutive Officer
- Ronald B RichardDirector
- Katherine StreiExecutive Officer
- Fuad El-HibriDirector, Executive Officer
- Adam R HaveyExecutive Officer
- Sue BaileyDirector
- Daniel J Abdun-NabiExecutive Officer, Director
- Louis W SullivanDirector
- Zsolt HarsanyiDirector
- Kathryn C ZoonDirector
- Jerome M HauerDirector
- Richard S. LindahlExecutive Officer
- Atul SaranExecutive Officer
- Offering amount
- $47.9M
- Amount sold
- $47.9M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Acquisitions · 1
Early investors' stakes continue via these dealsTrubion
Acquired by Emergent BioSolutions